{
 "PrintNo":"A9267","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2022-02-09T09:23:32.057712Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-02-09","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2022-02-09","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":662,"Name":"John T. McDonald III","Short":"MCDONALD"},{"ID":675,"Name":"Phil Steck","Short":"STECK"}],
 "Title":"Requires a utilization review agent to follow certain rules when establishing a step therapy protocol",
 "Summary":"Requires a utilization review agent to follow certain rules when establishing a step therapy protocol; requires that the protocol accepts any attestation submitted by the insured's health care professional stating that a required drug has failed as prima facie evidence that the required drug has failed.",
 "LawSection":"Insurance Law","LawCode":"Amd §§4902 & 4903, Ins L; amd §§4902 & 4903, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to requiring a utilization review agent to follow certain rules when establishing a step therapy protocol",
 "SameAsPrintNo":"S8191-2021"
}